Lynn Minai Azary - 06 Jun 2025 Form 4 Insider Report for Context Therapeutics Inc. (CNTX)

Role: Chief Financial Officer
Signature: /s/ Alex Levit, Attorney-in-Fact
Issuer symbol: CNTX
Transactions as of: 06 Jun 2025
Net transactions value: +$25,486
Form type: 4
Filing time: 10 Jun 2025, 17:22:20 UTC
Previous filing: 14 Feb 2025
Next filing: 23 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Minai-Azary Jennifer Lynn	Chief Financial Officer	2001 MARKET STREET, SUITE 3915, UNIT #15, PHILADELPHIA	/s/ Alex Levit, Attorney-in-Fact	10 Jun 2025	0001844398

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CNTX	Common Stock	Purchase	$25,486	+40,010	+100%	$0.6370	80,010	06 Jun 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.57 - $0.68. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Content

The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.57 - $0.68. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.